Home/Filings/4/0001870278-25-000011
4//SEC Filing

Smith Michael Alexander 4

Accession 0001870278-25-000011

CIK 0001104506other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 4:08 PM ET

Size

21.5 KB

Accession

0001870278-25-000011

Insider Transaction Report

Form 4
Period: 2025-11-03
Smith Michael Alexander
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-03$23.75/sh+27,130$644,33882,032 total
  • Sale

    Common Stock

    2025-11-03$181.88/sh7,619$1,385,74473,071 total
  • Sale

    Common Stock

    2025-11-03$181.01/sh1,342$242,91580,690 total
  • Sale

    Common Stock

    2025-11-03$183.92/sh4,032$741,56564,753 total
  • Sale

    Common Stock

    2025-11-03$184.91/sh3,243$599,66361,510 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-0327,1300 total
    Exercise: $23.75Exp: 2030-01-03Common Stock (27,130 underlying)
  • Sale

    Common Stock

    2025-11-03$182.60/sh4,286$782,62468,785 total
  • Sale

    Common Stock

    2025-11-03$185.93/sh3,636$676,04157,874 total
  • Sale

    Common Stock

    2025-11-03$187.15/sh1,572$294,20056,302 total
  • Sale

    Common Stock

    2025-11-03$187.97/sh1,400$263,15854,902 total
Footnotes (10)
  • [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F10]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
  • [F2]This is the weighted average sales price representing 1,342 shares sold at prices ranging from $180.29 to $181.19 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F3]This is the weighted average sales price representing 7,619 shares sold at prices ranging from $181.30 to $182.29 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F4]This is the weighted average sales price representing 4,286 shares sold at prices ranging from $182.30 to $183.03 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F5]This is the weighted average sales price representing 4,032 shares sold at prices ranging from $183.49 to $184.48 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F6]This is the weighted average sales price representing 3,243 shares sold at prices ranging from $184.50 to $185.48 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F7]This is the weighted average sales price representing 3,636 shares sold at prices ranging from $185.51 to $186.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F8]This is the weighted average sales price representing 1,572 shares sold at prices ranging from $186.61 to $187.53 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F9]This is the weighted average sales price representing 1,400 shares sold at prices ranging from $187.88 to $188.13 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Issuer

INSMED Inc

CIK 0001104506

Entity typeother

Related Parties

1
  • filerCIK 0001870278

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:08 PM ET
Size
21.5 KB